Avaliação do perfil de suscetibilidade de Mycobacterium tuberculosis frente a agentes tuberculostáticos no âmbito do Hospital Universitário de Santa Maria

Detalhes bibliográficos
Autor(a) principal: Agertt, Vanessa Albertina
Data de Publicação: 2012
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Biblioteca Digital de Teses e Dissertações do UFSM
Texto Completo: http://repositorio.ufsm.br/handle/1/6018
Resumo: The Mycobacterium genus includes M. tuberculosis complex (CMTB) species and others called nontuberculous mycobacteria (MNT). The CMTB bacilli cause tuberculosis (TB), a bacterial infectious disease, which commonly affects the lungs. Since the MNT cause other mycobacterial infections. The correct diagnosis of diseases caused by mycobacteria is essential for determining treatment. The tuberculosis treatment regimen in Brazil is recommended by the National Tuberculosis Control/Ministry of Health (PNCT/MS) and was recently modified. The main changes proposed by the Technical Advisory Committee of PNCT/MS were: to introduce a fourth drug, ethambutol, during the attack and take the combination of drugs in tablet form, with fixed-dose combinations (FDC) 4 in 1, for intensive treatment phase, and 2 in 1 for the maintenance phase. Due to the high incidence of tuberculosis in Brazil and worldwide, the emergence of resistant strains and the deployment of new therapies by the Ministry of Health, this study aimed to evaluate the susceptibility to antituberculosis or individually associated clinical isolates of Mycobacterium tuberculosis from the University Hospital Mary. The antimicrobial susceptibility alone or associated (rifampicin, isoniazid, pyrazinamide and ethambutol) was evaluated using the microdilution method (MMC) and compared to the proportion method (MP), gold standard method for susceptibility to mycobacteria. The MMC has proven to be a rapid, easily performed and well correlated with the MP. We have found various clinical isolates of M. tuberculosis resistant to one, two or three drug when tested against four drugs alone. However, when they were tested against four drugs associated with the FDC no strain was considered resistant. This fact is against the concept of FDC which aims to unite the four anti-TB drugs to combat the resistance of the bacilli.
id UFSM_296a557f84880a8094b18f3c120b5b23
oai_identifier_str oai:repositorio.ufsm.br:1/6018
network_acronym_str UFSM
network_name_str Biblioteca Digital de Teses e Dissertações do UFSM
repository_id_str
spelling 2015-11-052015-11-052012-07-31AGERTT, Vanessa Albertina. EVALUATION OF THE PROFILE OF SUSCEPTIBILITY Mycobacterium tuberculosis FRONT OF AGENTS TUBERCULOSTATIC UNDER THE UNIVERSITY HOSPITAL OF SANTA MARIA. 2012. 65 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2012.http://repositorio.ufsm.br/handle/1/6018The Mycobacterium genus includes M. tuberculosis complex (CMTB) species and others called nontuberculous mycobacteria (MNT). The CMTB bacilli cause tuberculosis (TB), a bacterial infectious disease, which commonly affects the lungs. Since the MNT cause other mycobacterial infections. The correct diagnosis of diseases caused by mycobacteria is essential for determining treatment. The tuberculosis treatment regimen in Brazil is recommended by the National Tuberculosis Control/Ministry of Health (PNCT/MS) and was recently modified. The main changes proposed by the Technical Advisory Committee of PNCT/MS were: to introduce a fourth drug, ethambutol, during the attack and take the combination of drugs in tablet form, with fixed-dose combinations (FDC) 4 in 1, for intensive treatment phase, and 2 in 1 for the maintenance phase. Due to the high incidence of tuberculosis in Brazil and worldwide, the emergence of resistant strains and the deployment of new therapies by the Ministry of Health, this study aimed to evaluate the susceptibility to antituberculosis or individually associated clinical isolates of Mycobacterium tuberculosis from the University Hospital Mary. The antimicrobial susceptibility alone or associated (rifampicin, isoniazid, pyrazinamide and ethambutol) was evaluated using the microdilution method (MMC) and compared to the proportion method (MP), gold standard method for susceptibility to mycobacteria. The MMC has proven to be a rapid, easily performed and well correlated with the MP. We have found various clinical isolates of M. tuberculosis resistant to one, two or three drug when tested against four drugs alone. However, when they were tested against four drugs associated with the FDC no strain was considered resistant. This fact is against the concept of FDC which aims to unite the four anti-TB drugs to combat the resistance of the bacilli.O gênero Mycobacterium é constituído por espécies do Complexo M. tuberculosis (CMTB) e outras denominadas de micobactérias não tuberculosas (MNT). Os bacilos do CMTB causam a tuberculose (TB), uma doença infecciosa bacteriana, a qual comumente afeta os pulmões. Já as MNT causam outras micobacterioses. O diagnostico correto das doenças causadas pelas micobactérias é essencial para a definição do tratamento. O esquema de tratamento para a tuberculose no Brasil é preconizado pelo Programa Nacional de Controle da Tuberculose/Ministério da Saúde (PNCT/MS) e foi recentemente modificado. As principais mudanças propostas pelo Comitê Técnico Assessor do PNCT/MS foram: introduzir um quarto fármaco, o etambutol, na fase de ataque e adotar a associação dos fármacos em forma de comprimidos, com doses fixas combinadas (DFC) 4 em 1, para a fase de tratamento intensivo, e, 2 em 1, para fase de manutenção. Devido à grande incidência da tuberculose no Brasil e no mundo, à emergência de cepas resistentes e à implantação de novas terapias pelo Ministério da Saúde, este trabalho objetivou avaliar a suscetibilidade aos tuberculostáticos associados ou individualmente dos isolados clínicos de Mycobacterium tuberculosis do Hospital Universitário de Santa Maria. A suscetibilidade aos antimicrobianos isolados ou associados (rifampicina, isoniazida, pirazinamida e etambutol) foi avaliada através do método de microdiluição em caldo (MMC) e comparados ao método das proporções (MP), método padrão ouro para suscetibilidade de micobactérias. O MMC mostrou-se ser um método rápido, de fácil realização e boa correlação com o MP. Foram encontrados vários isolados clínicos de M. tuberculosis resistentes a um, dois ou três fármacos quando testados frente aos quatro fármacos isoladamente. Porem, quando estes foram, testados contra os quatro fármacos da DFC associados nenhuma cepa foi considerada resistente. Este fato vem de encontro ao conceito da DFC a qual pretende unir os quatro medicamentos anti-TB para combater a resistência dos bacilos.Conselho Nacional de Desenvolvimento Científico e Tecnológicoapplication/pdfporUniversidade Federal de Santa MariaPrograma de Pós-Graduação em Ciências FarmacêuticasUFSMBRAnálises Clínicas e ToxicológicasDose fixa combinadaSuscetibilidadeMycobacterium tuberculosisMicobactérias não-tuberculosasMétodo de microdiluição em caldoMétodo das proporçõesFixed dose combinationSusceptibilityMycobacterium tuberculosisNontuberculous micobactériasMicrodiluation broth metodProportion metodCNPQ::CIENCIAS DA SAUDE::FARMACIAAvaliação do perfil de suscetibilidade de Mycobacterium tuberculosis frente a agentes tuberculostáticos no âmbito do Hospital Universitário de Santa MariaEvaluation of the profile of susceptibility Mycobacterium tuberculosis front of agents tuberculostatic under the University Hospital of Santa Mariainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisCampos, Marli Matiko Anraku dehttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4737495P6Alves, Sydney Hartzhttp://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4780857U6Santos, Roberto Christ Viannahttp://lattes.cnpq.br/9176719594431835http://lattes.cnpq.br/4128871371021894Agertt, Vanessa Albertina201000000000400500300500500ac8e430f-6a47-4d8e-91cd-2fd828e1aa377ff973e5-a47b-4af8-bc8f-c1fc75e899567928080e-16be-47fd-b0a3-6d394fcd82a7d8266a15-f797-4b1b-820c-51f0bf795787info:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações do UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSMORIGINALAGERTT, VANESSA ALBERTINA.pdfapplication/pdf477113http://repositorio.ufsm.br/bitstream/1/6018/1/AGERTT%2c%20VANESSA%20ALBERTINA.pdfbf220b87544e1a54157c59ce2cdd3474MD51TEXTAGERTT, VANESSA ALBERTINA.pdf.txtAGERTT, VANESSA ALBERTINA.pdf.txtExtracted texttext/plain118555http://repositorio.ufsm.br/bitstream/1/6018/2/AGERTT%2c%20VANESSA%20ALBERTINA.pdf.txt69c8522aa0123936dbed20eb323e9eaeMD52THUMBNAILAGERTT, VANESSA ALBERTINA.pdf.jpgAGERTT, VANESSA ALBERTINA.pdf.jpgIM Thumbnailimage/jpeg5269http://repositorio.ufsm.br/bitstream/1/6018/3/AGERTT%2c%20VANESSA%20ALBERTINA.pdf.jpgd419cb1d2b6f4ff89a32c8e89ed9b3f0MD531/60182022-10-10 11:54:14.467oai:repositorio.ufsm.br:1/6018Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2022-10-10T14:54:14Biblioteca Digital de Teses e Dissertações do UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.por.fl_str_mv Avaliação do perfil de suscetibilidade de Mycobacterium tuberculosis frente a agentes tuberculostáticos no âmbito do Hospital Universitário de Santa Maria
dc.title.alternative.eng.fl_str_mv Evaluation of the profile of susceptibility Mycobacterium tuberculosis front of agents tuberculostatic under the University Hospital of Santa Maria
title Avaliação do perfil de suscetibilidade de Mycobacterium tuberculosis frente a agentes tuberculostáticos no âmbito do Hospital Universitário de Santa Maria
spellingShingle Avaliação do perfil de suscetibilidade de Mycobacterium tuberculosis frente a agentes tuberculostáticos no âmbito do Hospital Universitário de Santa Maria
Agertt, Vanessa Albertina
Dose fixa combinada
Suscetibilidade
Mycobacterium tuberculosis
Micobactérias não-tuberculosas
Método de microdiluição em caldo
Método das proporções
Fixed dose combination
Susceptibility
Mycobacterium tuberculosis
Nontuberculous micobactérias
Microdiluation broth metod
Proportion metod
CNPQ::CIENCIAS DA SAUDE::FARMACIA
title_short Avaliação do perfil de suscetibilidade de Mycobacterium tuberculosis frente a agentes tuberculostáticos no âmbito do Hospital Universitário de Santa Maria
title_full Avaliação do perfil de suscetibilidade de Mycobacterium tuberculosis frente a agentes tuberculostáticos no âmbito do Hospital Universitário de Santa Maria
title_fullStr Avaliação do perfil de suscetibilidade de Mycobacterium tuberculosis frente a agentes tuberculostáticos no âmbito do Hospital Universitário de Santa Maria
title_full_unstemmed Avaliação do perfil de suscetibilidade de Mycobacterium tuberculosis frente a agentes tuberculostáticos no âmbito do Hospital Universitário de Santa Maria
title_sort Avaliação do perfil de suscetibilidade de Mycobacterium tuberculosis frente a agentes tuberculostáticos no âmbito do Hospital Universitário de Santa Maria
author Agertt, Vanessa Albertina
author_facet Agertt, Vanessa Albertina
author_role author
dc.contributor.advisor1.fl_str_mv Campos, Marli Matiko Anraku de
dc.contributor.advisor1Lattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4737495P6
dc.contributor.referee1.fl_str_mv Alves, Sydney Hartz
dc.contributor.referee1Lattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4780857U6
dc.contributor.referee2.fl_str_mv Santos, Roberto Christ Vianna
dc.contributor.referee2Lattes.fl_str_mv http://lattes.cnpq.br/9176719594431835
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/4128871371021894
dc.contributor.author.fl_str_mv Agertt, Vanessa Albertina
contributor_str_mv Campos, Marli Matiko Anraku de
Alves, Sydney Hartz
Santos, Roberto Christ Vianna
dc.subject.por.fl_str_mv Dose fixa combinada
Suscetibilidade
Mycobacterium tuberculosis
Micobactérias não-tuberculosas
Método de microdiluição em caldo
Método das proporções
topic Dose fixa combinada
Suscetibilidade
Mycobacterium tuberculosis
Micobactérias não-tuberculosas
Método de microdiluição em caldo
Método das proporções
Fixed dose combination
Susceptibility
Mycobacterium tuberculosis
Nontuberculous micobactérias
Microdiluation broth metod
Proportion metod
CNPQ::CIENCIAS DA SAUDE::FARMACIA
dc.subject.eng.fl_str_mv Fixed dose combination
Susceptibility
Mycobacterium tuberculosis
Nontuberculous micobactérias
Microdiluation broth metod
Proportion metod
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS DA SAUDE::FARMACIA
description The Mycobacterium genus includes M. tuberculosis complex (CMTB) species and others called nontuberculous mycobacteria (MNT). The CMTB bacilli cause tuberculosis (TB), a bacterial infectious disease, which commonly affects the lungs. Since the MNT cause other mycobacterial infections. The correct diagnosis of diseases caused by mycobacteria is essential for determining treatment. The tuberculosis treatment regimen in Brazil is recommended by the National Tuberculosis Control/Ministry of Health (PNCT/MS) and was recently modified. The main changes proposed by the Technical Advisory Committee of PNCT/MS were: to introduce a fourth drug, ethambutol, during the attack and take the combination of drugs in tablet form, with fixed-dose combinations (FDC) 4 in 1, for intensive treatment phase, and 2 in 1 for the maintenance phase. Due to the high incidence of tuberculosis in Brazil and worldwide, the emergence of resistant strains and the deployment of new therapies by the Ministry of Health, this study aimed to evaluate the susceptibility to antituberculosis or individually associated clinical isolates of Mycobacterium tuberculosis from the University Hospital Mary. The antimicrobial susceptibility alone or associated (rifampicin, isoniazid, pyrazinamide and ethambutol) was evaluated using the microdilution method (MMC) and compared to the proportion method (MP), gold standard method for susceptibility to mycobacteria. The MMC has proven to be a rapid, easily performed and well correlated with the MP. We have found various clinical isolates of M. tuberculosis resistant to one, two or three drug when tested against four drugs alone. However, when they were tested against four drugs associated with the FDC no strain was considered resistant. This fact is against the concept of FDC which aims to unite the four anti-TB drugs to combat the resistance of the bacilli.
publishDate 2012
dc.date.issued.fl_str_mv 2012-07-31
dc.date.accessioned.fl_str_mv 2015-11-05
dc.date.available.fl_str_mv 2015-11-05
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv AGERTT, Vanessa Albertina. EVALUATION OF THE PROFILE OF SUSCEPTIBILITY Mycobacterium tuberculosis FRONT OF AGENTS TUBERCULOSTATIC UNDER THE UNIVERSITY HOSPITAL OF SANTA MARIA. 2012. 65 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2012.
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/6018
identifier_str_mv AGERTT, Vanessa Albertina. EVALUATION OF THE PROFILE OF SUSCEPTIBILITY Mycobacterium tuberculosis FRONT OF AGENTS TUBERCULOSTATIC UNDER THE UNIVERSITY HOSPITAL OF SANTA MARIA. 2012. 65 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2012.
url http://repositorio.ufsm.br/handle/1/6018
dc.language.iso.fl_str_mv por
language por
dc.relation.cnpq.fl_str_mv 201000000000
dc.relation.confidence.fl_str_mv 400
500
300
500
500
dc.relation.authority.fl_str_mv ac8e430f-6a47-4d8e-91cd-2fd828e1aa37
7ff973e5-a47b-4af8-bc8f-c1fc75e89956
7928080e-16be-47fd-b0a3-6d394fcd82a7
d8266a15-f797-4b1b-820c-51f0bf795787
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Ciências Farmacêuticas
dc.publisher.initials.fl_str_mv UFSM
dc.publisher.country.fl_str_mv BR
dc.publisher.department.fl_str_mv Análises Clínicas e Toxicológicas
publisher.none.fl_str_mv Universidade Federal de Santa Maria
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações do UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Biblioteca Digital de Teses e Dissertações do UFSM
collection Biblioteca Digital de Teses e Dissertações do UFSM
bitstream.url.fl_str_mv http://repositorio.ufsm.br/bitstream/1/6018/1/AGERTT%2c%20VANESSA%20ALBERTINA.pdf
http://repositorio.ufsm.br/bitstream/1/6018/2/AGERTT%2c%20VANESSA%20ALBERTINA.pdf.txt
http://repositorio.ufsm.br/bitstream/1/6018/3/AGERTT%2c%20VANESSA%20ALBERTINA.pdf.jpg
bitstream.checksum.fl_str_mv bf220b87544e1a54157c59ce2cdd3474
69c8522aa0123936dbed20eb323e9eae
d419cb1d2b6f4ff89a32c8e89ed9b3f0
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações do UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1801485237108080640